Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/30/2010US20100247629 Method for drug loading in liposomes
09/30/2010US20100247628 Skin Treatment Compositions Containing Copper-Pigment Complexes
09/30/2010US20100247627 Foxn1 and pigmentation
09/30/2010US20100247626 Pegylated compounds for age-related macular degeneration
09/30/2010US20100247625 Orally Bioavailable Lipid-Based Constructs
09/30/2010US20100247621 Codon modified immunogenic compositions and methods of use
09/30/2010US20100247619 Nanostructured Lipid Carriers Containing Riluzole And Phamaceutical Formulations Containing Said Particles
09/30/2010US20100247617 Transdermal Administration Of (2S)-(4E)-N-Methyl-5-(3-(5-Isopropoxypyridin)yl)-4-Penten-2-Amine
09/30/2010US20100247614 Hemostatic wound dressing
09/30/2010US20100247612 Extrudable and extruded compositions for delivery of bioactive agents, method of making same and method of using same
09/30/2010US20100247610 Gastric retained gabapentin dosage form
09/30/2010US20100247607 Implantable formulations of bisphosphonic acids
09/30/2010US20100247606 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/30/2010US20100247602 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
09/30/2010US20100247600 Therapeutic drug eluting implant cover and method of making the same
09/30/2010US20100247599 Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device
09/30/2010US20100247597 Biocompatible Polymers for Coating or Fabricating Implantable Medical Devices
09/30/2010US20100247596 Element for implantation with medical device
09/30/2010US20100247591 Skin Treatment Compositions Containing Copper-Pigment Complexes
09/30/2010US20100247587 Pigmentation-regulating compounds
09/30/2010US20100247585 Stabilized pharmaceutical product
09/30/2010US20100247584 Compositions useful for treating gastroesophageal reflux disease
09/30/2010US20100247583 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
09/30/2010US20100247581 Edible product having an immunostimulating effect
09/30/2010US20100247564 Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
09/30/2010US20100247559 West nile virus vaccine, and method for production thereof
09/30/2010US20100247558 PEPTIDES INDUCING A CD4i CONFORMATION IN HIV gp120 WHILE RETAINING VACANT CD4 BINDING SITE
09/30/2010US20100247557 Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 Agonist
09/30/2010US20100247554 Use of tam receptor inhibitors as antimicrobials
09/30/2010US20100247553 Goodpasture Antigen Binding Protein
09/30/2010US20100247552 Pak modulators
09/30/2010US20100247551 Use of Lipocalin 2 in the Regulation of Insulin Sensitivity
09/30/2010US20100247548 Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
09/30/2010US20100247544 Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms
09/30/2010US20100247543 Treatment and prevention of neurodegenerative diseases
09/30/2010US20100247538 IL-18 and Protein Kinase R Inhibition for the Treatment of COPD
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247528 Arrays, kits and cancer characterization methods
09/30/2010US20100247525 Compositions and methods for treating anthrax lethality
09/30/2010US20100247520 Mutated netrin 4, fragments thereof and uses thereof as drugs
09/30/2010US20100247519 Heterocyclic aspartyl protease inhibitors
09/30/2010US20100247517 Use of mnk inhibitors for the treatment of alzheimer's disease
09/30/2010US20100247514 Gamma secretase modulators
09/30/2010US20100247505 Composition for Reducing the Level of Glucose, Malondialdehyde-Modified LDL, Homocysteine and/or C-Reactive Protein in Blood
09/30/2010US20100247504 Powder composition
09/30/2010US20100247478 Method for stabilizing vertebral body architecture
09/30/2010US20100247477 Supramolecular handcuffs in polymeric architecture
09/30/2010US20100247471 Phenoxy-pyrrolidine derivative and its use and compositions
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100247466 Cosmetic composition forming after application a supramolecular polymer
09/30/2010US20100247463 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
09/30/2010US20100247462 Synthesis of resveratrol-based natural products
09/30/2010US20100247461 Anti-inflammatory complexes
09/30/2010US20100247455 Periodontal Bacterial Growth Inhibitor, Oral Hygiene Product, and Food and Drink
09/30/2010US20100247454 Compositions for elastogenesis and connective tissue treatment
09/30/2010US20100247453 Composition and method of treating a sore throat
09/30/2010US20100247447 Drug delivery system for hydrophobic drugs
09/30/2010US20100247439 Dendritic nano-antioxidants
09/30/2010US20100247437 Materials and methods for the delivery of biomolecules to cells of an organ
09/30/2010US20100247434 Anti-Angiogenic Extracts from Pomegranate
09/30/2010US20100247433 Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells
09/30/2010US20100247432 Marker for the diagnosis of cancer
09/30/2010US20100247427 Methods of inhibiting cell growth and methods of enhancing radiation responses
09/30/2010DE102009015461A1 New O-acylated hydroxycarboxylic acid-polyol compounds obtained from O-acylated hydroxycarboxylic acid- and polyol-compound, useful e.g. to treat microbial diseases, preferably bacteria, virus and/or fungi/mold spores, and as food additive
09/30/2010DE102009014484A1 Substituierte Piperidine Substituted piperidines
09/30/2010CA2757067A1 Water soluble defructosylated pea extract, and use thereof as prebiotic agent
09/30/2010CA2756851A1 Therapeutic agent for cancer having reduced sensitivity to molecular target drug and pharmaceutical composition for enhancing sensitivity to molecular target drug
09/30/2010CA2756786A1 Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
09/30/2010CA2756779A1 Compositions and methods for treatment of renal disease
09/30/2010CA2756769A1 Fluoroquinolone carboxylic acid molecular crystals
09/30/2010CA2756757A1 A topical parasiticide composition
09/30/2010CA2756750A1 A method for producing bicyclic .gamma.-amino acid derivative
09/30/2010CA2756645A1 Therapeutic uses of quinazolinedione derivatives
09/30/2010CA2756566A1 Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
09/30/2010CA2756554A1 Method for increasing concentration of avenanthramides in oats
09/30/2010CA2756536A1 Thienopyrimidinedione derivatives as trpa1 modulators
09/30/2010CA2756535A1 Furopyrimidinedione derivatives as trpa1 modulators
09/30/2010CA2756534A1 Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
09/30/2010CA2756532A1 Substituted spiro-amide compounds
09/30/2010CA2756518A1 Fused pyrimidinedione derivatives as trpa1 modulators
09/30/2010CA2756499A1 Pharmaceutical composition containing a drug and sirna
09/30/2010CA2756452A1 Methods and compositions for the treatment of cancer
09/30/2010CA2756428A1 Matrix-type sustained release preparation containing basic additive
09/30/2010CA2756422A1 Process for producing carboxylic acid compound
09/30/2010CA2756347A1 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
09/30/2010CA2756316A1 Methods for preventing and treating radiation-induced epithelial disorders
09/30/2010CA2756255A1 Substituted bicyclic hcv inhibitors
09/30/2010CA2756222A1 Transdermal delivery
09/30/2010CA2756181A1 Carrier
09/30/2010CA2756178A1 Compounds as cannabinoid receptor ligands
09/30/2010CA2756172A1 Inhibitors of hepatitis c virus replication
09/30/2010CA2756152A1 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
09/30/2010CA2756145A1 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
09/30/2010CA2756099A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
09/30/2010CA2756086A1 Pyrazole compound
09/30/2010CA2756070A1 Kanamycin antisense nucleic acid for the treatment of cancer
09/30/2010CA2756067A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
09/30/2010CA2756065A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/30/2010CA2756064A1 Process for the production of fused, tricyclic sulfonamides
09/30/2010CA2756005A1 Substituted piperidines as par-1 antagonists
1 ... 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 ... 7860